Vimarsana
Biggest News Aggregation in the World

Page 6 - Nasdaq Bbio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Bbio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Bbio Today - Breaking & Trending Today

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Recommendation of "Moderate Buy" by Brokerages - Vimarsana News

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) have been given an average recommendation of “Moderate Buy” by the ten analysts that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average […]

Source: wkrb13.com
Mizuho Markets Americas LLC Increases Stock Holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO) - Vimarsana News

Mizuho Markets Americas LLC Increases Stock Holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO)

Mizuho Markets Americas LLC lifted its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 5.1% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 94,198 shares of the company’s stock after purchasing an additional 4,600 shares during the quarter. Mizuho Markets […]

BridgeBio Pharma (NASDAQ:BBIO) Receives "Buy" Rating from Mizuho - Vimarsana News

BridgeBio Pharma (NASDAQ:BBIO) Receives "Buy" Rating from Mizuho

Mizuho restated their buy rating on shares of BridgeBio Pharma (NASDAQ:BBIO – Free Report) in a report released on Monday morning, Benzinga reports. The firm currently has a $60.00 target price on the stock. Several other equities analysts have also recently issued reports on BBIO. BTIG Research raised their price target on BridgeBio Pharma from […]

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives Consensus Recommendation of "Moderate Buy" from Analysts - Vimarsana News

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) have been given a consensus rating of “Moderate Buy” by the ten research firms that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and nine have given a buy rating to the company. The average […]

BridgeBio Pharma Target of Unusually Large Options Trading (NASDAQ:BBIO) - Vimarsana News

BridgeBio Pharma Target of Unusually Large Options Trading (NASDAQ:BBIO)

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) was the recipient of unusually large options trading on Monday. Stock investors purchased 10,304 call options on the stock. This is an increase of approximately 43% compared to the typical volume of 7,221 call options. Analyst Upgrades and Downgrades A number of equities research analysts have issued […]

Source: wkrb13.com